Korean J Dermatol.
2012 Feb;50(2):159-162.
Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis
- Affiliations
-
- 1Department of Dermatology, Dongguk University Ilsan Hospital, College of Medicine, Dongguk University, Goyang, Korea. lay5604@naver.com
Abstract
- Vitiligo is an acquired cutaneous disorder of pigmentation with no definite etiology. Although there are a number of treatment modalities including phototherapy, topical corticosteroids and topical immunomodulators, few studies on the effect of systemic cyclosporine for the treatment of vitiligo have been conducted. We have experienced the improvement of vitiligo lesions after 8 months of systemic administration of cyclosporine (2.5~3.3 mg/kg/day) in a patient with vitiligo and atopic dermatitis. We believe this case report warrants further investigations of cyclosporine for the treatment of vitiligo in terms of mechanisms and clinical outcomes as well.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Vitiligo Lesions Stopped Spreading after Oral Cyclosporine in a Vitiligo Patient Who Shows Systemic Steroid Resistance
- An Unusual Case of Psoriasis Confined to Vitiligo Lesions
- Bilateral Segmental Vitiligo
- Contact Vitiligo Associated with Allergic Contact Dermatitis to Para-phenylenediamine
- The Comparison of Therapeutic Effectiveness Between Lesional and Whole Body Exposure on Oral PUVA for Generalized Vitiligo
